Related Experiment Videos
What drug must be used to avoid the most common hypertensive complications?
1Cattedra di Medicina Interna e Insegnamento delle Malattie Cardiovascolari nella Scuola di Specializzazione in Diabetologia e Malattie del Ricambio, Seconda Università degli Studi, Naples, Italy.
Insights
Hypertension management involves understanding angiotensin mechanisms and drug classes like ACE-inhibitors, AT1-receptor blockers, and new beta-blockers. Diuretics and calcium antagonists offer additional benefits for cardiovascular complications.
Area of Science:
- Cardiology
- Pharmacology
- Hypertension Research
Background:
- Cardiovascular complications are the leading cause of death and illness in hypertensive patients.
- Understanding the mechanisms behind elevated angiotensin levels in hypertension is crucial.
Purpose of the Study:
- To review the mechanisms of increased angiotensin in hypertensive patients.
- To explain the actions of various antihypertensive drug classes.
Main Methods:
- Literature review and synthesis of existing research on hypertension pharmacotherapy.
- Explanation of drug mechanisms of action.
Main Results:
- Detailed description of the role of angiotensin in hypertension.
- Illustration of the effects of ACE-inhibitors versus AT1-receptor blockers.
- Explanation of the antihypertensive actions of Carvedilol and Nebivolol.
- Summary of diuretic effects on brain hemorrhage and heart failure.
- Highlighting the anti-calcinotic and anti-embolic effects of calcium antagonists.
Conclusions:
- Various drug classes, including ACE-inhibitors, AT1-receptor blockers, beta-blockers, diuretics, and calcium antagonists, play vital roles in managing hypertension and its cardiovascular complications.
Abstract:
After recalling that cardiovascular complications represent the most frequent cause of mortality and morbidity in hypertensive patients, the author describes the main mechanism responsible for increased plasma level concentrations of Angiotensin in this syndrome. He subsequently illustrates the effects of ACE-inhibitors, differentiating them from AT1-receptors. The anti-hypertensive actions of new b-blockers, like Carvedilol and Nebivolol are also explained. In addition, the anti brain hemorrhage and heart-failure effects of diuretics in hypertensive patients are briefly summarised. Finally, the anti-calcinotic effect and anti-embolic action of calcium-antagonist drugs are also underlined.